Terms: = Colorectal cancer AND TFEB, TCFEB, 7942, ENSG00000112561, P19484, AlphaTFEB AND Treatment
4 results:
1. Periplocin suppresses the growth of colorectal cancer cells by triggering LGALS3 (galectin 3)-mediated lysophagy.
Wang K; Fu S; Dong L; Zhang D; Wang M; Wu X; Shen E; Luo L; Li C; Nice EC; Huang C; Zou B
Autophagy; 2023 Dec; 19(12):3132-3150. PubMed ID: 37471054
[TBL] [Abstract] [Full Text] [Related]
2. A new glance at autophagolysosomal-dependent or -independent function of transcriptional factor EB in human cancer.
Wang T; Qin Y; Ye Z; Jing DS; Fan GX; Liu MQ; Zhuo QF; Ji SR; Chen XM; Yu XJ; Xu XW; Li Z
Acta Pharmacol Sin; 2023 Aug; 44(8):1536-1548. PubMed ID: 37012494
[TBL] [Abstract] [Full Text] [Related]
3. colorectal cancer inhibitory properties of polysaccharides and their molecular mechanisms: A review.
Ruan J; Zhang P; Zhang Q; Zhao S; Dang Z; Lu M; Li H; Zhang Y; Wang T
Int J Biol Macromol; 2023 May; 238():124165. PubMed ID: 36963537
[TBL] [Abstract] [Full Text] [Related]
4. Transcriptome profiling analysis reveals that ATP6V0E2 is involved in the lysosomal activation by anlotinib.
Sun X; Shu Y; Yan P; Huang H; Gao R; Xu M; Lu L; Tian J; Huang D; Zhang J
Cell Death Dis; 2020 Aug; 11(8):702. PubMed ID: 32839434
[TBL] [Abstract] [Full Text] [Related]
